These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 10987283)
1. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Yamada T; Takaoka AS; Naishiro Y; Hayashi R; Maruyama K; Maesawa C; Ochiai A; Hirohashi S Cancer Res; 2000 Sep; 60(17):4761-6. PubMed ID: 10987283 [TBL] [Abstract][Full Text] [Related]
2. Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of beta-catenin/T-cell factor 4-mediated gene transactivation. Naishiro Y; Yamada T; Takaoka AS; Hayashi R; Hasegawa F; Imai K; Hirohashi S Cancer Res; 2001 Mar; 61(6):2751-8. PubMed ID: 11289158 [TBL] [Abstract][Full Text] [Related]
3. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis. Takahashi M; Fujita M; Furukawa Y; Hamamoto R; Shimokawa T; Miwa N; Ogawa M; Nakamura Y Cancer Res; 2002 Oct; 62(20):5651-6. PubMed ID: 12384519 [TBL] [Abstract][Full Text] [Related]
4. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Tetsu O; McCormick F Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372 [TBL] [Abstract][Full Text] [Related]
5. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320 [TBL] [Abstract][Full Text] [Related]
6. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics. Wakita K; Tetsu O; McCormick F Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869 [TBL] [Abstract][Full Text] [Related]
7. Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas. Venesio T; Balsamo A; Scordamaglia A; Bertolaso M; Arrigoni A; Sprujevnik T; Rossini FP; Risio M Mod Pathol; 2003 Jan; 16(1):57-65. PubMed ID: 12527714 [TBL] [Abstract][Full Text] [Related]
8. Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice. Yamada T; Mori Y; Hayashi R; Takada M; Ino Y; Naishiro Y; Kondo T; Hirohashi S Cancer Res; 2003 Mar; 63(5):895-901. PubMed ID: 12615699 [TBL] [Abstract][Full Text] [Related]
9. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138 [TBL] [Abstract][Full Text] [Related]
10. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Takahashi M; Tsunoda T; Seiki M; Nakamura Y; Furukawa Y Oncogene; 2002 Aug; 21(38):5861-7. PubMed ID: 12185585 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin. Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053 [TBL] [Abstract][Full Text] [Related]
12. Identification of AF17 as a downstream gene of the beta-catenin/T-cell factor pathway and its involvement in colorectal carcinogenesis. Lin YM; Ono K; Satoh S; Ishiguro H; Fujita M; Miwa N; Tanaka T; Tsunoda T; Yang KC; Nakamura Y; Furukawa Y Cancer Res; 2001 Sep; 61(17):6345-9. PubMed ID: 11522623 [TBL] [Abstract][Full Text] [Related]
13. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer. Takahashi M; Nakamura Y; Obama K; Furukawa Y Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202 [TBL] [Abstract][Full Text] [Related]
14. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc. Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729 [TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Sparks AB; Morin PJ; Vogelstein B; Kinzler KW Cancer Res; 1998 Mar; 58(6):1130-4. PubMed ID: 9515795 [TBL] [Abstract][Full Text] [Related]
16. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling. Dihlmann S; Siermann A; von Knebel Doeberitz M Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997 [TBL] [Abstract][Full Text] [Related]
17. [beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma]. Brabletz T; Jung A; Dag S; Reu S; Kirchner T Verh Dtsch Ges Pathol; 2000; 84():175-81. PubMed ID: 11217438 [TBL] [Abstract][Full Text] [Related]
19. Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Hlubek F; Jung A; Kotzor N; Kirchner T; Brabletz T Cancer Res; 2001 Nov; 61(22):8089-93. PubMed ID: 11719433 [TBL] [Abstract][Full Text] [Related]
20. Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. Shimokawa T; Furukawa Y; Sakai M; Li M; Miwa N; Lin YM; Nakamura Y Cancer Res; 2003 Oct; 63(19):6116-20. PubMed ID: 14559787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]